课题基金 / 基金详情

Molecular regulatory mechanism of cell surface garbohydrate expression and its pathology.

Molecular regulatory mechanism of cell surface garbohydrate expression and its pathology.
细胞表面碳水化合物表达的分子调控机制及其病理学。
批准号:
05454163
负责人:
YAMAOKA Kazuko
金额:
$4.1万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1995

项目摘要

项目成果

YAMAOKA Kazuko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
(1) Intramolecular disulfide bonds are essential for the tumor growth factor activity of TGF_<gamma>2 : Amino acid sequence analysis of TGF_<gamma>2 revealed the identity 14Kda galactoside-binding protein (galectin-1) .The TGF_<gamma>2 purified from rat tumor cells, however, showed no sugar-binding activity.To analyze the difference in each activity between TGF_<gamma>2 and galectin-1, we studied the intramolecular disulfide bonds in TGF and galectin-1 by the several methods including chemical clevage of S-S bridge, MOLD-mass spectrometry and affinity chromatography.Several lines of evidences indicated that intramolecular S-S bonds in TFG_<gamma>2 is required for TGF activity and that the lectin activity is induced by thecleavage of S-S bonds in TGF_<gamma>2, possibly as a result of the conformational change.(2) Molecular cloning, expression and specificity of GD3 synthase : We obtained the cDNA encoding GD3 synthase by the expression cloning strategy.The substrate specificy of the cloned GD3 synthase showed that this enzyme synthesizes not only GD3, but GQ1b which was believed by the other sialyltransferase, SAT5.These results suggest this enzyme play a key role in the regulation of ganglioside expression in CNS.
期刊论文(44)
专著(0)
科研奖励(0)
会议论文
Hidari,K.I.J.P.: "A unique biosynthetic pathway for gangliosides exist in Xenopus laevis oocytes" FEBS letters. 353. 25-28 (1994)
Hidari,K.I.J.P.:“非洲爪蟾卵母细胞中存在一种独特的神经节苷脂生物合成途径”FEBS 信件。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
NARA,K.: ""Expression cloning of a CMP-NeuAc : NeuAcalpha2,3 Galbeta1,4Glcbeta1,1'Cer alpha2,8-Sialyltransferase (GD3 Synthase) from Human Melanoma Cells."" Proc.Natl.Acad.Sci.USA. 91. 7952-7956 (1994)
NARA,K.:“从人黑色素瘤细胞中表达克隆 CMP-NeuAc:NeuAcalpha2,3 Galbeta1,4Glcbeta1,1Cer α2,8-唾液酸转移酶(GD3 合酶)。”Proc.Natl.Acad.Sci.USA
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
KAZUKO YAMAOKA: "Structural and functional characterization of a novel tumorderived rat galectin-1 having transforming growth factor(TGF)activity" J. of Biochemistry. (in press). (1996)
KAZUKO YAMAOKA:“具有转化生长因子 (TGF) 活性的新型肿瘤源性大鼠半乳糖凝集素-1 的结构和功能表征”《生物化学杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hidari,K.I.J.P.: "In vitro synthesis of disialoganglioside(GD1alpha) from asialo-GM1 using sialyltransferase" Eur.J.Biochem.221. 603-609 (1994)
Hidari,K.I.J.P.:“使用唾液酸转移酶从 asialo-GM1 体外合成二唾液酸神经节苷脂 (GD1α)”Eur.J.Biochem.221。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
21
    Analysis of phosphotyroisine-containing proteins related to the malignancy in gliomas by proteomic differential display
    国内基金
    海外基金
    IL-27通过NFATC4介导Galectin 9表达调控T细胞亚群促进外周T细胞淋巴瘤进展的机制研究
    Galectin3阳性脂肪干细胞促进肥胖诱导的脂肪组织炎症的作用及机制研究
    • 批准号:
      2026JJ30025
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      邓沱
    • 依托单位:
    丹参提取物抑制Galectin- 1靶向RACK1改善糖尿病肾损伤的机制研究
    • 批准号:
      2026JJ82135
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      邓薇
    • 依托单位:
    血清Galectin-3-NLRP3轴致心房颤动心房纤维化的机制与干预研究
    • 批准号:
      2026JJ82494
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      李纯
    • 依托单位: